Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Standard of Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 12 Colorectal Neoplasms 12 Breast Neoplasms 10 Prostatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 5 Urinary Bladder Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Breast Carcinoma In Situ 4 Sarcoma 3 Motor Activity 3 Leukemia, Myeloid, Acute 3 Stomach Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Follicular 2 Lymphedema 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Frailty 2 Fallopian Tube Neoplasms 2 Carcinoma, Squamous Cell 2

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡